Zobrazeno 1 - 10
of 304
pro vyhledávání: '"L. Ingham"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Diana L. Ingham
Title from PDF of title page (University of Missouri--Columbia, viewed on January 26, 2011).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95a8d90c4548e0ac9ec52d8d6459fbfa
https://doi.org/10.32469/10355/9883
https://doi.org/10.32469/10355/9883
Autor:
Sarah L Ingham, Narendra Nath Basu, D G Evans, Fiona Lalloo, M. Bulman, Anthony Howell, James Hodson
Publikováno v:
Familial Cancer. 14:531-538
BRCA1 and BRCA2 mutation carriers have an increased risk of contralateral breast cancer after primary breast cancer. Risk reduction strategies are discussed after assessment of risk factors for developing contralateral breast cancer. We assessed pote
Autor:
Anthony Howell, Gary L Ross, Iain Buchan, Andrew D Baildam, Sarah L Ingham, Fiona Lalloo, D. Gareth Evans
Publikováno v:
Breast Cancer Research and Treatment. 140:135-142
BRCA1/2 mutation carriers with breast cancer are at high risk of contralateral disease. Such women often elect to have contralateral risk-reducing mastectomy (CRRM) to reduce the likelihood of recurrence. This study considers whether CRRM improves ov
Autor:
Clark, C. L. Ingham
Publikováno v:
BMJ: British Medical Journal, 1995 Feb . 310(6978), 512-514.
Externí odkaz:
https://www.jstor.org/stable/29726450
Publikováno v:
BMJ: British Medical Journal, 1992 Oct . 305(6860), 1005-1008.
Externí odkaz:
https://www.jstor.org/stable/29717399
Autor:
Wood, R. F. M., Clark, C. L. Ingham
Publikováno v:
BMJ: British Medical Journal, 1992 Jun 01. 304(6840), 1453-1454.
Externí odkaz:
https://www.jstor.org/stable/29715824
Autor:
Iain Buchan, Jane Warwick, Anthony Moran, D G R Evans, Sarah Sahin, A Howell, Catherine O'Hara, Sarah L Ingham
Publikováno v:
Cancer Research. 72:P3-08
Since the identification of the BRCA1 and BRCA2 genes speculation has continued regarding the breast and ovarian cancer risk associated with mutations in these genes. Also, as to whether mutations in these genes account for the majority of the associ
Publikováno v:
Clinical Genetics. 84:37-42
BRCA1 and BRCA2 are major breast cancer susceptibility genes. Nineteen single nucleotide polymorphisms (SNPs) at 18 loci have been associated with breast cancer. We aimed to determine whether these predict breast cancer incidence in women with BRCA1/
Autor:
Susan M. Astley, Jane Warwick, Sarah L Ingham, Iain Buchan, Sarah Sahin, William G. Newman, Roderic Warren, Ursula Beetles, Paula Stavrinos, D. G. R. Evans, B Eckersley, Henrietta McBurney, Alan Hufton, Mary E. Wilson, Anthony Howell, Jamie C. Sergeant, Jack Cuzick, Michelle Harvie
Publikováno v:
Journal of Internal Medicine. 271:321-330
Breast cancer is not only increasing in the west but also particularly rapidly in eastern countries where traditionally the incidence has been low. The rise in incidence is mainly related to changes in reproductive patterns and lifestyle. These trend